Not applicableStudy completedNCT00528138What this trial is testingHyperbilirubinemia in Acute Appendicitis as a Predictor of PerforationWho this might be right forPerforated Appendicitis Cirujanos la Serena 132
Early research (Phase 1)Study completedNCT00036959What this trial is testingABT-751 in Treating Young Patients With Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more National Institutes of Health Clinical Center (CC) 90
Early research (Phase 1)Study completedNCT02094625What this trial is testingNAC to Prevent Cisplatin-induced Hearing LossWho this might be right forNeuroectodermal Tumors, PrimitiveLiver NeoplasmsOsteosarcoma+1 more Children's Hospital Los Angeles 52
Not applicableStudy completedNCT05695989What this trial is testingSafety and Feasibility of the Use of the Dual Robotic Arm Accessory With the Levita Magnetic Surgical System in Laparoscopic ProceduresWho this might be right forBariatric Surgery CandidateCholelithiasesOther Disease Levita Magnetics 22
Testing effectiveness (Phase 2)Ended earlyNCT06069778What this trial is testingSafety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic AdenocarcinomaWho this might be right forPancreatic Cancer BioNTech SE 1
Testing effectiveness (Phase 2)Looking for participantsNCT04585750What this trial is testingThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)Who this might be right forAdvanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more PMV Pharmaceuticals, Inc 300
Post-approval studies (Phase 4)Study completedNCT04074460What this trial is testingVolatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility StudyWho this might be right forCancer, BreastCancer ColorectalCancer Prostate+3 more Peter MacCallum Cancer Centre, Australia 169
Early research (Phase 1)Study completedNCT01048892What this trial is testingSeneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine FeaturesWho this might be right forAdrenocortical CarcinomaGastrointestinal Carcinoid TumorKidney Cancer+3 more Children's Oncology Group 22
Early research (Phase 1)Looking for participantsNCT06621563What this trial is testingPhase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid TumorsWho this might be right forSolid TumorsNon-Small Cell Lung CancerColorectal Cancer Hansoh BioMedical R&D Company 780
Testing effectiveness (Phase 2)Ended earlyNCT05716295What this trial is testingA Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid Tumors Medikine, Inc. 26
Early research (Phase 1)Study completedNCT00101270What this trial is testingOxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasWho this might be right forChildhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Diffuse Large Cell Lymphoma+26 more National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05205330What this trial is testingVorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI CancersWho this might be right forRefractory Metastatic Colorectal CancerSolid TumorMetastatic Microsatellite-stable Colorectal Cancer+3 more Rottapharm Biotech 107
Testing effectiveness (Phase 2)Looking for participantsNCT03539822What this trial is testingCabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal MalignanciesWho this might be right forGastric CancerEsophageal AdenocarcinomaHepatocellular Carcinoma+1 more Anwaar Saeed 117
Not applicableEnded earlyNCT02503631What this trial is testingStool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract CancersWho this might be right forColorectal NeoplasmsDigestive System DiseasesColonic Diseases+1 more Exact Sciences Corporation 397
Not applicableApproved For MarketingNCT03906331What this trial is testingExpanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) ActivationWho this might be right forNon Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+4 more Eli Lilly and Company
Not applicableLooking for participantsNCT01950572What this trial is testingTissue Procurement and Natural History Study of Patients With Malignant MesotheliomaWho this might be right forMesotheliomaThymomaPancreatic Neoplasms+2 more National Cancer Institute (NCI) 1,000
Not applicableLooking for participantsNCT05013944What this trial is testingAnovaOS Network Powered Patient RegistryWho this might be right forInfectious DiseaseNeoplasmsDiseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89)+18 more Anova Enterprises, Inc 100,000
Early research (Phase 1)Study completedNCT00655083What this trial is testingA Phase I Study to Evaluate the Oral Absorption of Nepadutant in InfantsWho this might be right forInfantile ColicInfantile Functional Gastrointestinal Disorders Menarini Group 21
Testing effectiveness (Phase 2)Study completedNCT00019760What this trial is testingIsolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the LiverWho this might be right forRecurrent Colon CancerLiver MetastasesStage IV Rectal Cancer+2 more National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Ended earlyNCT04637009What this trial is testingTAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid NeoplasmsWho this might be right forAcute Myeloid LeukemiaMyeloproliferative NeoplasmMyelodysplastic/Myeloproliferative Neoplasm Astex Pharmaceuticals, Inc. 20